...
【24h】

Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature

机译:青光眼扩散装置在uveitic青光眼中的疗效和文献的荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

PurposeTo assess the efficacy of glaucoma drainage devices (GDD) in uveitic glaucoma and non-uveitic glaucoma, and to perform a meta-analysis of previously published results to compare with our data.MethodsRetrospective case-control study, in which all eyes that underwent GDD surgery were included from 2015 onwards. Cases were defined as patients with uveitic glaucoma. Patients with non-uveitic glaucoma served as controls. To compare our results, a review of the literature was performed using PubMed database.ResultsA total of 99 eyes were included (38 with uveitic glaucoma). The preoperative IOP was 25.97.7mmHg and 27.9 +/- 9.6mmHg for patients with and without uveitis (p=0.277). No significant differences were found between patients with and without uveitis in the final IOP or reduction in IOP (44.9% vs. 42.8%, respectively). Within the first year after surgery, 13.2% of cases developed macular edema (vs. 6.6%; p=0.267) and 15.8% a transient hypotony (vs. 8.2%; p=0.242). A meta-analysis of 24 studies showed a postoperative weighted mean difference of -17.8mmHg and 2.2 lower number of IOP-lowering medications in uveitic glaucoma (compared to -13.2mmHg and 3.5 in the current study, respectively).Conclusionp id=Par4GDD surgery in patients with uveitis has a similar effect on IOP as in patients without uveitis. The risks of developing macular edema and hypotony were slightly higher in patients with uveitis, but the results were not statistically significant. These findings are in line with previous reports, though data on the efficacy of GDD surgery and macular edema in uveitic glaucoma is scarce.
机译:purposeto评估了青光眼扩散装置(Gdd)在uveitic青光眼和非葡萄质胶质瘤中的疗效,并对先前公布的结果进行了荟萃分析,以与我们的数据进行比较。方法对照案例对照研究,其中所有的眼睛都会受到GDD的所有眼睛从2015年开始,手术包括在2015年。病例被定义为患有uveitic青光眼的患者。患有非脓细胞神经胶质瘤的患者作为对照。为了比较我们的结果,使用Pubmed Database进行了对文献的审查。包括99只眼睛的审查,包括99只眼睛(38带uveiticGlaucoma)。术前IOP为25.97.7mmHg和27.9 +/- 9.6mmHg,适用于患者,无葡萄质炎(P = 0.277)。在最终IOP或IOP降低的患者中没有葡萄膜炎的患者没有发现显着差异(分别为42.8%)。在手术后的第一年内,13.2%的病例发育了黄斑水肿(与6.6%; p = 0.267)和15.8%的瞬态低间止(与8.2%; p = 0.242)。 24项研究的Meta分析显示出术后加权平均差异为-17.8mmHg和2.2次葡萄质青光眼的Iop降低药物数量较少(与当前研究中的-13.2mMHg和3.5相比).Clusionp ID = PAR4GDD手术在葡萄膜炎的患者中对没有葡萄膜炎的患者的IOP具有类似的效果。葡萄膜炎患者的开发黄斑水肿和低声的风险略高,但结果没有统计学意义。这些发现符合先前的报告,尽管对葡萄球菌的GDD手术和黄斑水肿的疗效数据稀缺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号